Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.
about
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@ast
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@en
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@nl
type
label
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@ast
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@en
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@nl
prefLabel
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@ast
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@en
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Randomized phase 2 study of bo ...... ate-sensitive prostate cancer.
@en
P2093
Ana Aparicio
Christopher J Logothetis
Franklin C Wong
John C Araujo
Lance C Pagliaro
Marcella M Johnson
Mehmet Asim Bilen
Michael J Fisch
Nizar M Tannir
Paul G Corn
P2860
P356
10.1002/CNCR.28971
P407
P577
2014-08-22T00:00:00Z